Brief: Orchid Pharma Receives Dcgi Approval For Antibiotic Drug Combination Of Cefepime, Enmetazobactam
June 6 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* RECEIVES DCGI APPROVAL FOR ANTIBIOTIC DRUG COMBINATION OF
CEFEPIME AND ENMETAZOBACTAM
* APPROVAL PAVES WAY FOR LAUNCH OF INJECTABLE THERAPY FOR
PATIENTS
IN INDIA
* PERMISSION ALSO TO MANUFACTURE FINISHED DOSAGE FORM OF
CEFEPIME,
ENMETAZOBACTAM AS DRY POWDER INJECTABLE
Source text for Eikon: ID:nBSE6Vcg9s
Further company coverage: ORCD.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices